| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |